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available template for modelling pro-
tein-protein “docking” interactions. 
The Kbdock project is run as a collabo-
ration between the Capsid and
Orpailleur teams at the Loria/Inria
research center in Nancy. It is funded
and supported by Inria, the CNRS, and
the University of Lorraine, as well as
specific ANR (“Agence Nationale pour
la Recherche”) grants. The Kbdock pro-
gram is available through its online
interface. It may also be queried pro-
grammatically by expert users in order
to execute complex or specialised
queries. Recent developments to
Kbdock make use of a novel protein
structure alignment algorithm called
“Kpax” that we have developed [3].
This allows queries in Kbdock to span
structural neighbours of the retrieved
DDIs, thus allowing Kbdock to search
over more distant regions of protein
structure space and to propose protein
docking templates that cannot be found
using conventional sequence-based or
structure-based comparison techniques. 
We are currently working to link
KBdock's structural domain binding
site classification with the widely used
ExPASy Enzyme Classification
scheme. In order to achieve this, we are
developing efficient data-mining
approaches to process the millions of
sequence-function associations that are
now available in large molecular
biology databases, such as Swiss-Prot
and TrEMBL, which together build the
UniProt Knowledgebase at the
European Bioinformatics Institute.
Links:
http://kbdock.loria.fr
http://kpax.loria.fr, http://hex.loria.fr
Protein Data Bank:
http://www.rcsb.org/pdb/home/home.do
Pfam domain classification:
http://pfam.xfam.org/
UniProt Knowledgebase:
http://www.ebi.ac.uk/uniprot
ExPASy: http://enzyme.expasy.org
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The sequencing of the first human
genome was completed in 2003 (though a
draft was already complete by 2001). This
achievement cost 100 million US dollars
and took 13 years. Now, only 12 years
later, the cost for the equivalent process
has dropped to just over $1,000 and takes
just a few days. As a consequence,
sequencing the human exome (the coding
part of the genome), for example, or the
whole genome, has become common
practice in medicine, and genomic
sequencing of many other species has
paved the way to new challenges and
research fields in the life sciences.
The first breakthrough in the history of
DNA sequencing was the development
of Frederick Sanger's method using
chain-termination with dideoxy
nucleotides in 1977, which earned
Sanger his second Nobel Prize in 1980.
Sanger sequencing (SSeq) is a
sequencing-by-synthesis technique
since it requires DNA polymerase
enzymes to produce the observable
output by means of nucleotide radiola-
belling or fluorescent dyes.
From around 2005-2006, second-gener-
ation sequencing (SGS) produced a dra-
matic cost reduction, and from that
point on, we have seen a growing diffu-
sion of sequencing machines that have
revolutionised clinical research and
practice, as well as molecular biology
investigations in genomics [1]. The
higher error rate (compared with SSeq)
is balanced out by the impressive
throughput of SGS platforms. Though
they still rely on sequence-by-synthesis
(using chemi- or photo-luminescence),
these platforms are based on various
implementations of cyclic-array
sequencing. SGS methods (in particular
Illumina and Roche) are  widely used
for the investigation of the whole spec-
trum of genomic variants from single
nucleotide variants (SNVs) to structural
variants (SVs). Other implementations
of SGS include SOLiD and Complete
Genomics' nanoball sequencing.
Notably, Ion Torrent was the first plat-
form based on non-optical (i.e., electro-
chemical) methods 
Today’s low cost of sequencing allows
any reasonably funded lab to sequence
multiple genomes, thus raising new
clinic and research issues. Sequencing
several individuals of the same species,
for example, is now common for per-
sonalised medicine and for under-
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Where does this huge amount of data come from? What are the costs of producing it? The answers to
these questions lie in the impressive development of sequencing technologies, which have opened up
many research opportunities and challenges, some of which are described in this issue. DNA
sequencing is the process of “reading” a DNA fragment (referred to as a “read”) and determining the
exact order of DNA bases (the four possible nucleotides, that are Adenine, Guanine, Cytosine, and
Thymine) that compose a given DNA strand. Research in biology and medicine has been
revolutionised and accelerated by the advances of DNA and even RNA sequencing biotechnologies.
standing how we differ genetically from
each other. Also, RNA-Seq – that is
sequencing genes that are transcribed for
proteins synthesis – allows us to take a
(possibly comparative) picture of which
genes are expressed under certain condi-
tions. Moreover, sequencing several
strands of the same species allows us to
investigate intra-species mutations that
involve the mobile element of the
genomes. Finally, “metagenomics”
studies the microbiology of genetic
material that is recovered from non-culti-
vated environments (e.g., soil, gut, sea-
depths) and sequenced.
A new revolution is currently underway
with “third-generation sequencing”
(TGS) techniques [2]. These platforms
are based on single molecule real time
sequencing, a single DNA molecule
sequencing approach. While PacBio
platforms exploit an optical detection
method, Oxford Nanopore Technolo-
gies are based on ionic current measure-
ments [3]. Both platforms show high
error rates, though the length of the
reads produced is up to thousands of
base-pairs. When we have a robust (i.e.,
low error rates) technology capable of
such long reads – which will probably
be soon – we will certainly witness new
challenges in genomics.
The machine costs and sizes vary con-
siderably, as does the throughput (that
is, the amount sequenced base-pairs
per hour), even within the same gener-
ation. In general, both price and size
grow with the throughput. Machines
range from the huge and expensive
Illumina HiSeq (as big as a closet) to
the smaller (desktop-sized) Illumina
MiSeq and Ion Torrent, and the even
smaller USB-sized Nanopore MinION,
shown in Figure 1, passing through the
desktop sized ones. Other performance
parameters can instead be grouped
according to generation: Table 1
reports the cost per base of sequencing,
the length of fragments that can be
output, and the error rate for each tech-
nology generation.
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Figure 1: USB-sized Nanopore MinION.
Method Cost per Base ($/Mbp) Read Length Error Rate
SSEQ 400 (up to 2007) 300-1000 10-5-10-2
SGS 0.015 (2015) O(102) 10-2
TGS 0.5 (PacBio), 0.65 (Nanopore) O(103) 10-1
